Back to Results
First PageMeta Content
Anatomy / Osteopathies / Osteoporosis / Alendronic acid / Bone density / Bone fracture / Raloxifene / Risedronic acid / Menopause / Medicine / Bisphosphonates / Health


Changes to the Special Authorization Criteria for Anti-resorptive Agents in the treatment of osteoporosis
Add to Reading List

Document Date: 2010-04-07 12:30:35

Open Document

File Size: 54,31 KB

Share Result on Facebook

Country

Canada / /

IndustryTerm

treatment of osteoporosis / treatment for osteoporosis / /

MedicalCondition

primary osteoporosis / osteoporosis / postmenopausal osteoporosis / bone metastases / /

Product

Actonel / Miacalcin / prednisone / Evista / /

SocialTag